Insulin Resistance in Perimenopause Is Making Your Hot Flashes Worse
Women come to me after years of being told their hot flashes are simply a hormone problem. Hormones are part of it. But the part nobody explains is that your metabolic health at the start of perimenopause is already shaping how early those symptoms begin, how long they last, and how severe they become. That is not a theory. A 2026 study in the Journal of Clinical Endocrinology and Metabolism confirmed it with longitudinal data from 704 women tracked across a decade of menopausal change.
The question researchers asked was simple and long overdue: do insulin levels early in perimenopause predict how women experience menopause symptoms over the following 10 years? The answer was yes. Higher fasting insulin at age 47 predicted earlier onset of hot flashes, longer duration, and a greater overall burden of vasomotor symptoms. Crucially, insulin resistance during perimenopause predicted this independently of body weight. Body mass index, when both were modeled together, lost its statistical significance.
This is the insulin resistance perimenopause connection that conventional medicine is not testing for and not explaining. And it matters because, unlike the hormonal shifts of menopause itself, insulin levels are something you can change.
How Insulin Resistance in Perimenopause Predicts Hot Flashes
Researchers used data from the Study of Women’s Health Across the Nation (SWAN), a long-term cohort that followed 704 women from pre- or perimenopause through the full menopausal transition. Fasting insulin was measured at age 47. Vasomotor symptoms, hormone levels, and other metabolic markers were tracked across 10 annual visits.
Here’s what they found:
Each additional standard deviation in fasting insulin at age 47, roughly 5.6 µIU/mL above the study average, corresponded to a 14% higher hazard of developing hot flashes (HR = 1.14, 95% CI 1.05 to 1.24). Women with higher fasting insulin began experiencing hot flashes nearly 1.14 years earlier on average. Night sweats came on earlier too. The duration of hot flash experience across the follow-up period was also significantly longer for women with higher baseline insulin.
Cold sweats showed a 20% higher hazard per standard deviation increase in insulin (HR = 1.20). That is not a subtle effect.
When researchers put both fasting insulin and BMI into the same statistical model, insulin remained independently significant for hot flash incidence. BMI did not. That is the key finding: insulin resistance during perimenopause is not just a byproduct of excess weight. It is a distinct metabolic driver with its own direct relationship to vasomotor symptoms.
Insulin and Testosterone: The Hidden Hormonal Shift
Body mass index showed a different pattern. Higher BMI was associated with a slower decline in estradiol and a more gradual rise in FSH across the transition. That is the estrogen-dominant picture conventional medicine recognizes.
Insulin told a different story. Higher fasting insulin at age 47 was associated with a steeper rise in testosterone across the menopausal transition. This is the hyperandrogenic pattern: elevated androgens alongside elevated insulin. That combination is associated with poor heart outcomes and increased risk of type 2 diabetes. Nobody in conventional medicine is connecting those dots during a menopause appointment.
Insulin Resistance Perimenopause: What Functional Medicine Actually Tests
This is exactly what I see at Living Well Dallas. Women arrive with severe, frequent hot flashes. Sometimes they are already on hormone therapy and still struggling. When we run their metabolic labs, we find elevated fasting insulin, poor insulin sensitivity, and a hormonal pattern that looks more like metabolic dysfunction than simple estrogen withdrawal.
Conventional medicine does not include a fasting insulin panel in a standard menopause workup. It is not on the checklist. So the insulin resistance perimenopause connection goes undiagnosed, and women are left managing symptoms that have a metabolic root cause with tools that only address the hormonal surface.
This matters for another reason, too: insulin levels respond to lifestyle interventions faster than body weight does. Aerobic exercise and resistance training lower fasting insulin and improve insulin sensitivity independent of weight loss. Reducing refined carbohydrates and supporting stable blood sugar produces meaningful changes in insulin even when the scale does not move. The SWAN researchers noted this directly: insulin may be “a more attainable target” than body weight.
For women in their 40s who are already noticing early hot flashes or night sweats, that finding is actionable right now.
What to Do If You Are in Perimenopause With High Insulin
If you are in your mid-40s and already noticing early vasomotor symptoms, your metabolic health at this moment is shaping what the next decade looks like. That is a reason to look at the full picture now, before the transition intensifies.
A comprehensive perimenopause workup includes fasting insulin, fasting glucose, and an estimate of insulin resistance alongside the standard hormone panel. Add cortisol patterns, thyroid function, and inflammatory markers, and you start to see the actual clinical picture. Most conventional practitioners do not run this panel at all. The result is a woman who is told her hormones are “within normal range” while her fasting insulin is 14 µIU/mL and climbing.
Exercise prescription matters here. Resistance training has a particularly strong effect on insulin sensitivity, and midlife women who lift consistently show better metabolic profiles across the menopausal transition. This is not a secondary lifestyle recommendation. For women with insulin resistance during perimenopause, exercise is a core intervention with direct effects on symptom burden.
For women who are not in the Dallas area, Menrva Health offers the same root-cause metabolic approach through telehealth in all 50 states, including comprehensive lab panels and personalized hormone and metabolic protocols.
Key Takeaways
- Higher fasting insulin in early perimenopause, measured at age 47, predicted earlier onset and longer duration of hot flashes and night sweats in a JCEM study of 704 women.
- Each 5.6 µIU/mL increase in fasting insulin at midlife corresponded to a 14% higher hazard of developing hot flashes (HR 1.14), independent of body weight.
- Insulin predicted hot flash incidence independently of BMI. Body weight lost its significance when both were in the same model.
- Higher perimenopausal insulin is linked to steeper testosterone rises across the transition, creating a hyperandrogenic state associated with cardiovascular and metabolic risk.
- Fasting insulin responds to exercise and dietary interventions faster than body weight does, making it a practical clinical target before and during the menopausal transition.
Frequently Asked Questions
Can high insulin levels cause hot flashes? The SWAN study data shows that higher fasting insulin in early perimenopause independently predicts earlier onset and longer duration of hot flashes. The relationship held even when body weight was controlled. Insulin appears to affect the hypothalamic neurons that regulate body temperature, producing a narrowed thermoneutral zone and greater susceptibility to hot flash triggers.
What is the connection between insulin resistance and perimenopause? During the menopausal transition, declining estrogen worsens insulin resistance, and elevated insulin amplifies hormone dysregulation. The SWAN data shows that the relationship runs both directions: poor insulin sensitivity before menopause shapes how the transition unfolds. Women with higher fasting insulin in early perimenopause experienced worse vasomotor symptoms across the following decade.
Testing and Treating Insulin Resistance in Midlife Women
Does my doctor test insulin as part of a menopause workup? Typically, no. Standard menopause workups include estradiol, FSH, and sometimes testosterone. Fasting insulin is rarely included. A fasting insulin level and HOMA-IR score give meaningful information about metabolic risk that a standard hormone panel misses entirely. If your doctor is not ordering it, ask for it.
What is a normal fasting insulin level for a woman in her 40s? Conventional lab ranges often report up to 20 µIU/mL as normal. Functional medicine targets below 5 µIU/mL as optimal. The SWAN study found meaningful symptom differences across the normal distribution, with average insulin at 10.1 µIU/mL among participants. Lower insulin levels were associated with a better menopausal transition even within the conventionally accepted range.
Lifestyle and Hormone Approaches to Insulin in Perimenopause
Can diet and exercise improve insulin resistance before menopause makes symptoms worse? Yes. Both aerobic exercise and resistance training lower fasting insulin and improve insulin sensitivity independent of weight loss. Reducing refined carbohydrates and prioritizing protein shift insulin dynamics in a direction that the SWAN data suggests could meaningfully improve the menopausal experience. The earlier you start, the more runway you have.
If I am already in perimenopause with bad hot flashes, is it too late to improve insulin levels? No. Insulin levels respond to intervention at any stage. Improving metabolic health through diet, exercise, and targeted support can reduce vasomotor symptom burden even after symptoms have already begun. The connection between insulin resistance during perimenopause and symptom severity means that addressing your metabolic picture is always a relevant clinical intervention, not something to defer.
Dr. Betty’s Bottom Line
I have run fasting insulin panels on perimenopausal women for years, long before this research confirmed what I was seeing clinically. Women with high fasting insulin have harder menopausal transitions. More hot flashes, more night sweats, more sleep disruption, more difficulty with body composition during this period. Treating only the hormone side and ignoring the metabolic picture leaves half the problem unaddressed.
This SWAN study brings rigorous longitudinal data to what functional medicine clinicians have been observing for decades. The insulin resistance perimenopause connection is real, it is measurable, and it is modifiable. That is exactly the kind of finding I want every woman in her 40s to understand. “I can’t control my hormones” is a different conversation than “I can change my metabolic environment right now.” Because you can. And what happens in your metabolism now shapes what menopause looks and feels like for the next 10 years.
At our practice, we test comprehensively: fasting insulin, HOMA-IR, cortisol, thyroid, and the full hormone panel. We build individualized protocols that address the root cause. The outcomes are different when you treat the whole picture. You are not alone in this, and you deserve more than a referral to a sleep aid.
In-person care at Living Well Dallas is available for patients in the Dallas area. Menrva Health offers a comprehensive perimenopause and metabolic workup through telehealth in all 50 states.
Source: Athar F, Gregory S, Houston EJ, Templeman NM. Insulin Levels Early in Perimenopause Inform Vasomotor Symptom Incidence Across the Menopausal Transition. J Clin Endocrinol Metab. 2026. doi:10.1210/clinem/dgaf699